HapMap SNP Scanner: An online program to mine SNPs responsible for cell phenotype

Tissue Antigens

Volumn 80, Issue 2, 2012, Pages 119-125

  Yamamura, T ^a   Hikita, J ^b   Bleakley, M ^c   Hirosawa, T ^a   Sato Otsubo, A ^d   Torikai, H ^a   Hamajima, T ^c   Nannya, Y ^d   Demachi Okamura, A ^a   Maruya, E ^e   Saji, H ^e   Yamamoto, Y ^b   Takahashi, T ^a   Emi, N ^b   Morishima, Y ^a   Kodera, Y ^f   Kuzushima, K ^a   Riddell, S R ^c   Ogawa, S ^d   Akatsuka, Y ^a,b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c USA   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

^e Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

^f AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Genome wide association study; HapMap; Minor histocompatibility antigen; Online software; Single nucleotide polymorphism

Indexed keywords

LEUKOCYTE ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ARTICLE; COMPUTER PROGRAM; GENE MAPPING; GRAFT VERSUS HOST REACTION; HAPMAP SINGLE NUCLEOTIDE POLYMORPHISM SCANNER; HUMAN; HUMAN TISSUE; INFORMATION SERVICE; ONLINE SYSTEM; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

B-LYMPHOCYTES; CELL LINE; CHROMOSOME MAPPING; DATA MINING; GENOTYPE; HAPMAP PROJECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; INTERNET; LINKAGE DISEQUILIBRIUM; MINOR HISTOCOMPATIBILITY ANTIGENS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SOFTWARE; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84864335470     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2012.01883.x     Document Type: Article

References (23)

1. Nebert DW, Zhang G, Vesell ES. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev 2008: 40: 187-224.
2. Weiner MP, Hudson TJ. Introduction to SNPs: discovery of markers for disease. BioTechniques 2002: 10 (Suppl 2-4): 4-7.
3. Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev 2004: 4: 371-80.
4. Spierings E, Goulmy E. Expanding the immunotherapeutic potential of minor histocompatibility antigens. J Clin Invest 2005: 115: 3397-400.
5. Brickner AG, Warren EH, Caldwell JA et al. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 2001: 193: 195-206.
6. den Haan JM, Meadows LM, Wang W et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science (New York, NY) 1998: 279: 1054-7.
7. Dolstra H, Fredrix H, Maas F et al. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med 1999: 189: 301-8.
8. Kawase T, Akatsuka Y, Torikai H et al. Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen. Blood 2007: 110: 1055-63.
9. de Rijke B, van Horssen-Zoetbrood A, Beekman JM et al. A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. J Clin Invest 2005: 115: 3506-16.
10. Akatsuka Y, Nishida T, Kondo E et al. Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J Exp Med 2003: 197: 1489-500.
11. Bleakley M, Otterud BE, Richardt JL et al. Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood 2011: 115: 4923-33.
12. Kawase T, Nannya Y, Torikai H et al. Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA. Blood 2008: 111: 3286-94.
13. Kamei M, Nannya Y, Torikai H et al. HapMap scanning of novel human minor histocompatibility antigens. Blood 2009: 113: 5041-8.
14. Spaapen RM, Lokhorst HM, van den Oudenalder K et al. Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis. J Exp Med 2008: 205: 2863-72.
15. International HapMap Consortium. The International HapMap Project. Nature 2003: 426: 789-96.
16. Frazer KA, Ballinger DG, Cox DR et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007: 449: 851-61.
17. International HapMap Consortium. A haplotype map of the human genome. Nature 2005: 437: 1299-320.
18. Huang RS, Duan S, Bleibel WK et al. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci U S A 2007: 104: 9758-63.
19. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999: 50: 213-9.
20. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994: 152: 163-75.
21. Akatsuka Y, Goldberg TA, Kondo E et al. Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens 2002: 59: 502-11.
22. Spaapen RM, de Kort RA, van den Oudenalder K et al. Rapid identification of clinical relevant minor histocompatibility antigens via genome-wide zygosity-genotype correlation analysis. Clin Cancer Res 2009: 15: 7137-43.
23. Rajesh D, Dickerson SJ, Yu J, Brown ME, Thomson JA, Seay NJ. Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells. Blood 118: 1797-800.